Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 01/29/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol Myers Squibb Merck & Co., Inc. |
None | None | None | ✔ |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta Merck & Co., Inc. |
Regeneron Pharmaceuticals, Inc. | None | None | ✔ |
| Joel Baumgartner MD | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Genevieve Boland MD, PhD | Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. |
Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | None | - |
| Bartosz Chmielowski MD, PhD | Advenchen Laboratories Aeglea Biotherapeutics Array Biopharma Ascentage Bristol Myers Squibb Compugen Daiichi- Sankyo Co. Eli Lilly and Company EMD Serono IDEAYA Biosciences Idera Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Macrogenics Merck & Co., Inc. Neon Therapeutics Novartis Pharmaceuticals Corporation Oncosec PACT Pharma RAPT Therapeutics Replimune Tolero Pharmaceuticals Xencor |
Genzyme Corporation Iovance Biotherapeutics Oncosec |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Alison Durham MD | OncoSec Medical Incorporated | None | None | None | - |
| Anita Engh PhD | None | None | None | None | - |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | ✔ |
| Anjela Galan MD | None | None | None | None | - |
| Brian Gastman MD | Alkermes NIT |
Iovance | Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Kenneth Grossmann MD, PhD | Natera - investigator, and spouse is co-investigator, no paid salary or benefits to either of us | Array Bristol Myers Squibb Novartis Pharmaceuticals Corporation |
None | None | - |
| Samantha Guild JD | None | State of Texas | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Anne Holbrook PharmD, BCOP | None | None | None | None | - |
| Ashley Holder MD | None | None | None | None | ✔ |
| Douglas Johnson MD, MSCI | None | None | Bristol Myers Squibb Catalyst Biopharma Iovance Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | ✔ |
| Richard Joseph MD | Bristol Myers Squibb Exelixis Inc. |
None | None | None | ✔ |
| Giorgos Karakousis MD | Merck & Co., Inc. | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Kari Kendra MD, PhD | NA | NA | NA | NA | ✔ |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Ryan Lanning MD, PhD | None | None | None | None | - |
| Daniel Lui PharmD, BCPPS | None | None | Brand Institute Inc M3 MedPanel MNOW (Sermo) Reckner |
None | - |
| Kim Margolin MD | Checkmate Pharmaceuticals IOvance Pfizer Inc. |
ImaginAb Oncosec |
None | None | ✔ |
| Miguel Materin MD | None | Castle Biosciences | Carl Zeiss Meditec | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Anthony Olszanski MD, RPh | None | Bristol Myers Squibb Merck & Co., Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Patrick Ott MD, PhD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Celldex Therapeutics Cytomx Genentech, Inc. MedImmune Inc. Merck & Co., Inc. Neon Laboratories Pfizer Inc. Roche Laboratories, Inc. |
Array Biopharma Bristol Myers Squibb Celldex Therapeutics Cytomx Therapeutics Genentech, Inc. Merck & Co., Inc. Neon Laboratories Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Kumar Rao MD | None | None | None | None | - |
| Ramesh Rengan MD, PhD | None | AstraZeneca Pharmaceuticals LP | None | None | - |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | ✔ |
| April Salama MD | Bristol Myers Squibb Immunocore Merck & Co., Inc. |
Iovance Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Rohit Sharma MD | None | None | None | None | - |
| Joseph Skitzki MD | None | None | None | None | - |
| Jeffrey Sosman MD | None | Array Bristol Myers Squibb Curis Genentech, Inc. Nektar Therapeutics |
None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Susan Swetter MD | None | None | None | None | ✔ |
| John Thompson MD | Calithera Pharmaceuticals | Academy Continued Healthcare Learning Clinical Care Options Iovance Neoleukin |
AVEO Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. |
None | ✔ |
| Erin Vidic | None | None | None | None | - |
| Evan Wuthrick MD | Varian Medical Systems, Inc. | None | Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. |
None | - |